Fewer Danish teens experimenting with drugs

Just 1 percent of 15 to 16-year-olds in Denmark tried amphetamines or ecstasy in 2015.

Teenagers in Denmark are taking less drugs – most particularly cannabis, amphetamines and ecstasy – according to a new report from the health authority Sundhedsstyrelsen.

The report showed that just 1 percent of 15 to 16-year-olds in Denmark had tried amphetamines or ecstasy in 2015.

The report also showed that 13 percent of Danish teens had tried cannabis this year, while 1.5 percent of teens had tried LSD.

READ MORE: Hundreds imprisoned for door-to-door drugs deliveries

More deaths
Finally, figures from the state police Rigspolitiet showed that the number of Danes dying from drug use was on the increase.

The report revealed that the number of people who had died due to drug-related reasons had risen to 263 in 2014 from 213 in 2013.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.